Product Approval Information
Proper Name: Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine
Tradename: COMVAX
Manufacturer: Merck & Co., Inc, License #0002
Package Insert (PDF - 1.3 MB) - Approved: October 2, 1996
Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.
Date: October 2, 1996
Indication: Immunization of persons 6 weeks to 15 months of age born to hepatitis B surface antigen (HBsAg) negative mothers
October 2, 1996 Approval Letter
Summary for the Basis of Approval (PDF - 2 MB)